518 related articles for article (PubMed ID: 24116154)
1. Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.
Zhang W; Solanki M; Müther N; Ebel M; Wang J; Sun C; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e76771. PubMed ID: 24116154
[TBL] [Abstract][Full Text] [Related]
2. Integration profile and safety of an adenovirus hybrid-vector utilizing hyperactive sleeping beauty transposase for somatic integration.
Zhang W; Muck-Hausl M; Wang J; Sun C; Gebbing M; Miskey C; Ivics Z; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e75344. PubMed ID: 24124483
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.
Moldt B; Miskey C; Staunstrup NH; Gogol-Döring A; Bak RO; Sharma N; Mátés L; Izsvák Z; Chen W; Ivics Z; Mikkelsen JG
Mol Ther; 2011 Aug; 19(8):1499-510. PubMed ID: 21468003
[TBL] [Abstract][Full Text] [Related]
4. Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye.
Turunen TA; Laakkonen JP; Alasaarela L; Airenne KJ; Ylä-Herttuala S
J Gene Med; 2014; 16(1-2):40-53. PubMed ID: 24464652
[TBL] [Abstract][Full Text] [Related]
5. Hybrid lentivirus-transposon vectors with a random integration profile in human cells.
Staunstrup NH; Moldt B; Mátés L; Villesen P; Jakobsen M; Ivics Z; Izsvák Z; Mikkelsen JG
Mol Ther; 2009 Jul; 17(7):1205-14. PubMed ID: 19240688
[TBL] [Abstract][Full Text] [Related]
6. An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector.
Benati D; Cocchiarella F; Recchia A
J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364270
[TBL] [Abstract][Full Text] [Related]
7. Extending the transposable payload limit of Sleeping Beauty (SB) using the Herpes Simplex Virus (HSV)/SB amplicon-vector platform.
de Silva S; Mastrangelo MA; Lotta LT; Burris CA; Federoff HJ; Bowers WJ
Gene Ther; 2010 Mar; 17(3):424-31. PubMed ID: 19865178
[TBL] [Abstract][Full Text] [Related]
8. Transgene Expression and Transposition Efficiency of Two-Component Sleeping Beauty Transposon Vector Systems Utilizing Plasmid or mRNA Encoding the Transposase.
Tschorn N; van Heuvel Y; Stitz J
Mol Biotechnol; 2023 Aug; 65(8):1327-1335. PubMed ID: 36547824
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19.
Heister T; Heid I; Ackermann M; Fraefel C
J Virol; 2002 Jul; 76(14):7163-73. PubMed ID: 12072516
[TBL] [Abstract][Full Text] [Related]
10. A High-Capacity Adenoviral Hybrid Vector System Utilizing the Hyperactive Sleeping Beauty Transposase SB100X for Enhanced Integration.
Boehme P; Zhang W; Solanki M; Ehrke-Schulz E; Ehrhardt A
Mol Ther Nucleic Acids; 2016 Jul; 5(7):e337. PubMed ID: 27434682
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus/Sleeping Beauty vector-based embryonic gene transfer using the HSB5 mutant: loss of apparent transposition hyperactivity in vivo.
de Silva S; Mastrangelo MA; Lotta LT; Burris CA; Izsvák Z; Ivics Z; Bowers WJ
Hum Gene Ther; 2010 Nov; 21(11):1603-13. PubMed ID: 20507234
[TBL] [Abstract][Full Text] [Related]
12. Sleeping beauty transposition from nonintegrating lentivirus.
Vink CA; Gaspar HB; Gabriel R; Schmidt M; McIvor RS; Thrasher AJ; Qasim W
Mol Ther; 2009 Jul; 17(7):1197-204. PubMed ID: 19417741
[TBL] [Abstract][Full Text] [Related]
13. Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery.
Galla M; Schambach A; Falk CS; Maetzig T; Kuehle J; Lange K; Zychlinski D; Heinz N; Brugman MH; Göhring G; Izsvák Z; Ivics Z; Baum C
Nucleic Acids Res; 2011 Sep; 39(16):7147-60. PubMed ID: 21609958
[TBL] [Abstract][Full Text] [Related]
14. RNA interference is responsible for reduction of transgene expression after Sleeping Beauty transposase mediated somatic integration.
Rauschhuber C; Ehrhardt A
PLoS One; 2012; 7(5):e35389. PubMed ID: 22570690
[TBL] [Abstract][Full Text] [Related]
15. Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells.
Huang X; Haley K; Wong M; Guo H; Lu C; Wilber A; Zhou X
Hum Gene Ther; 2010 Nov; 21(11):1577-90. PubMed ID: 20528476
[TBL] [Abstract][Full Text] [Related]
16. Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition.
Bire S; Gosset D; Jégot G; Midoux P; Pichon C; Rouleux-Bonnin F
BMC Biotechnol; 2013 Sep; 13():75. PubMed ID: 24070093
[TBL] [Abstract][Full Text] [Related]
17. Development of adenovirus hybrid vectors for Sleeping Beauty transposition in large mammals.
Hausl M; Zhang W; Voigtländer R; Müther N; Rauschhuber C; Ehrhardt A
Curr Gene Ther; 2011 Oct; 11(5):363-74. PubMed ID: 21888620
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration.
Wang Y; Camp SM; Niwano M; Shen X; Bakowska JC; Breakefield XO; Allen PD
J Virol; 2002 Jul; 76(14):7150-62. PubMed ID: 12072515
[TBL] [Abstract][Full Text] [Related]
19. Construction and Quantitative Evaluation of a Tissue-Specific Sleeping Beauty by EDL2-Specific Transposase Expression in Esophageal Squamous Carcinoma Cell Line KYSE-30.
Mahmoudian RA; Fathi F; Farshchian M; Abbaszadegan MR
Mol Biotechnol; 2023 Mar; 65(3):350-360. PubMed ID: 35474410
[TBL] [Abstract][Full Text] [Related]
20. Development of the hybrid Sleeping Beauty: baculovirus vector for sustained gene expression and cancer therapy.
Luo WY; Shih YS; Hung CL; Lo KW; Chiang CS; Lo WH; Huang SF; Wang SC; Yu CF; Chien CH; Hu YC
Gene Ther; 2012 Aug; 19(8):844-51. PubMed ID: 21918552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
